These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36086752)

  • 21. Comprehensive analysis of a glycolysis and cholesterol synthesis-related genes signature for predicting prognosis and immune landscape in osteosarcoma.
    Xu F; Yan J; Peng Z; Liu J; Li Z
    Front Immunol; 2022; 13():1096009. PubMed ID: 36618348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of immune-related genes as prognostic biomarkers for the assessment of osteosarcoma clinical outcomes.
    Guo J; Li X; Shen S; Wu X
    Sci Rep; 2021 Dec; 11(1):24123. PubMed ID: 34916564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A potential prognostic prediction model for metastatic osteosarcoma based on bioinformatics analysis.
    Wang Y; Ming G; Gao B
    Acta Orthop Belg; 2023 Sep; 89(3):373-380. PubMed ID: 37935218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 12 Survival-related differentially expressed genes based on the TARGET-osteosarcoma database.
    Rothzerg E; Xu J; Wood D; Kõks S
    Exp Biol Med (Maywood); 2021 Oct; 246(19):2072-2081. PubMed ID: 33926256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishment of immune prognostic signature and analysis of prospective molecular mechanisms in childhood osteosarcoma patients.
    Zhang Z; Liu C; Liang T; Yu C; Qin Z; Zhou X; Xue J; Zeng H; Lu Z; Xu G; Wang Z; Chen J; Jiang J; Zhan X
    Medicine (Baltimore); 2020 Nov; 99(46):e23251. PubMed ID: 33181717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a novel vasculogenic mimicry-associated gene signature for the prognostic assessment of osteosarcoma patients.
    Yan L; Li R; Li D; Zhu Y; Lv Z; Wang B
    Clin Transl Oncol; 2023 Dec; 25(12):3501-3518. PubMed ID: 37219824
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma.
    Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H
    Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of 6 gene markers for survival prediction in osteosarcoma cases based on multi-omics analysis.
    Li R; Wang G; Wu Z; Lu H; Li G; Sun Q; Cai M
    Exp Biol Med (Maywood); 2021 Jul; 246(13):1512-1523. PubMed ID: 33563042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of 9-Gene Epithelial-Mesenchymal Transition Related Signature of Osteosarcoma by Integrating Multi Cohorts.
    Yiqi Z; Ziyun L; Qin F; Xingli W; Liyu Y
    Technol Cancer Res Treat; 2020; 19():1533033820980769. PubMed ID: 33308057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of an immune-related prognostic index associated with osteosarcoma.
    Yin CD; Hou YL; Liu XR; He YS; Wang XP; Li CJ; Tan XH; Liu J
    Bioengineered; 2021 Dec; 12(1):172-182. PubMed ID: 33371790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification and verification of a BMPs-related gene signature for osteosarcoma prognosis prediction.
    Xie L; Zeng J; He M
    BMC Cancer; 2023 Feb; 23(1):181. PubMed ID: 36814224
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of an EMT-related gene-based prognostic signature in osteosarcoma.
    Gong H; Tao Y; Xiao S; Li X; Fang K; Wen J; Zeng M; Liu Y; Chen Y
    Cancer Med; 2023 Jun; 12(11):12912-12928. PubMed ID: 37102261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of osteosarcoma cancer.
    Liu R; Hu Y; Liu T; Wang Y
    BMC Cancer; 2021 Dec; 21(1):1345. PubMed ID: 34922489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrating artificial intelligence in osteosarcoma prognosis: the prognostic significance of SERPINE2 and CPT1B biomarkers.
    Qu H; Jiang J; Zhan X; Liang Y; Guo Q; Liu P; Lu L; Yang Y; Xu W; Zhang Y; Lan S; Chen Z; Lu Y; Ou Y; Qin Y
    Sci Rep; 2024 Feb; 14(1):4318. PubMed ID: 38383657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dissecting the effect of sphingolipid metabolism gene in progression and microenvironment of osteosarcoma to develop a prognostic signature.
    Zhong Y; Zhang Y; Wei S; Chen J; Zhong C; Cai W; Jin W; Peng H
    Front Endocrinol (Lausanne); 2022; 13():1030655. PubMed ID: 36313783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Prognostic Model for Brain Glioma Patients Based on 9 Signature Glycolytic Genes.
    Bingxiang X; Panxing W; Lu F; Xiuyou Y; Chao D
    Biomed Res Int; 2021; 2021():6680066. PubMed ID: 34222480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of key biomarkers involved in osteosarcoma using altered modules.
    Liu ZZ; Cui ST; Tang B; Wang ZZ; Luan ZX
    Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrative analyses of ferroptosis and immune related biomarkers and the osteosarcoma associated mechanisms.
    Li G; Lei J; Xu D; Yu W; Bai J; Wu G
    Sci Rep; 2023 Apr; 13(1):5770. PubMed ID: 37031292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Verification of Ferroptosis Subcluster-Associated Genes Related to Osteosarcoma and Exploration of Immune Targeted Therapy.
    Jiang M; Jike Y; Gan F; Li J; Hu Y; Xie M; Liu K; Qin W; Bo Z
    Oxid Med Cell Longev; 2022; 2022():9942014. PubMed ID: 36211822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.